Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

8.8K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.8K
Regulated Protein Degradation02:58

Regulated Protein Degradation

3.1K
3.1K
Proteins: From Genes to Degradation02:11

Proteins: From Genes to Degradation

14.2K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick.  Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
14.2K
Proteins: From Genes to Degradation02:11

Proteins: From Genes to Degradation

4.2K
4.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NIR-Programmable Stealth 2D Black Phosphorus Nanobiointerfaces for Deep Tumor Penetration and Photoimmunotherapy.

ACS nano·2026
Same author

ALP-Responsive Luminescent Nanosheets Promote Precise Hepatitis Theragnostic by Co-Targeting NLRP3 and Cholestasis.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Sprayable nanozyme hydrogel epigenetically remodels inflammation for diabetic wound regeneration.

Nature communications·2026
Same author

Non-Invasive Brain Targeted Delivery of Cannabidiol for Alleviating Neuroinflammatory Disease.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

When Rare Is Not Small: Amyotrophic Lateral Sclerosis Initiatives and Therapy.

Exploration (Beijing, China)·2026
Same author

Nanodiamond-Mediated Targeted Delivery of Nanobodies and Immunostimulatory RNA for Breast Cancer Therapy.

ACS nano·2026

Related Experiment Video

Updated: Jan 22, 2026

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.4K

Nanoparticle-mediated targeting chimeras transform targeted protein degradation.

Yang Liu1,2,3, Xue Xia1,3, Yunjiao Zhang4

  • 1The Zhongzhou Laboratory for Integrative Biology, Henan International Joint Laboratory of Nanobiomedicine, School of Life Sciences, Henan University, Kaifeng, China.

Nature Nanotechnology
|January 20, 2026
PubMed
Summary
This summary is machine-generated.

Ligand-modified nanoparticles (NPs) offer a versatile platform for targeted protein degradation (TPD). This approach utilizes NPs to shuttle proteins for degradation, paving the way for adaptable

More Related Videos

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

11.0K
Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
08:26

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

12.6K

Related Experiment Videos

Last Updated: Jan 22, 2026

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.4K
High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

11.0K
Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
08:26

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

12.6K

Area of Science:

  • Biotechnology and Nanomedicine
  • Molecular Biology and Drug Discovery

Background:

  • Nanoparticles (NPs) are emerging as versatile tools in biotechnology.
  • Targeted protein degradation (TPD) is a rapidly advancing therapeutic strategy.
  • Current TPD methods often require complex, case-specific designs.

Purpose of the Study:

  • To explore the potential of ligand-modified NPs for targeted protein degradation (TPD).
  • To discuss the advantages of NP-mediated TPD over existing methods.
  • To highlight NP-mediated TPD as a potential 'plug-and-play' platform.

Main Methods:

  • Review of recent findings on NP-mediated protein degradation.
  • Analysis of the autolysosome-involved degradation pathway.
  • Discussion of NP and ligand characteristics in TPD.

Main Results:

  • Ligand-modified NPs can efficiently degrade extracellular and intracellular proteins.
  • Degradation occurs via an autolysosome pathway, independent of NP/ligand type.
  • NP-mediated TPD offers a broadly adaptable platform, moving beyond conventional delivery.

Conclusions:

  • NP-mediated TPD represents a significant advancement in protein degradation technologies.
  • This approach could revolutionize TPD by enabling a universal 'plug-and-play' system.
  • Further research into NP-mediated targeting chimeras for TPD is warranted.